Galleri Multi-Cancer Early Detection Test

Improve chances of early detection with the Galleri® test by GRAIL that detects for over 50 types of cancer through a simple blood draw.
mountain, highland, clouds-2563610.jpg

Galleri Multi-Cancer Early Detection Test

Improve chances of early detection with the Galleri® test by GRAIL that detects for over 50 types of cancer through a simple blood draw.

Featured In

Fierce Biotech Logo
Businesswire Logo
Healthline Logo
Men’sHealth Logo
USA Today Logo
Medscape Logo
Galleri Test


How It Works


Multi-Cancer Screening

Blood Test

Age and Cancer Risk

Did you know? Age is the most important risk factor for cancer overall. The incidence rate for cancer climbs steadily as age increases, from fewer than
25 cases per 100,000 under the age of 20, to more than 1,000 people aged
60 or older. (Source: National Institute)

Ready to Get Started?

Book Online Now.

Cancer Ribbon Logo

Early Detection Saves Lives

Take control of your health and screen for over 50 types of cancer—including many of the most common and the most deadly. All from a single lab visit.

  • Adrenal Cortical Carcinoma
  • Ampulla of Vater
  • Anal cancer
  • Appendix, Carcinoma
  • Bone cancer
  • Breast cancer
  • Cervical cancer
  • Colon & Rectum cancer
  • Esophagus & Esophagogastric Junction cancer
  • Gallbladder cancer
  • Gastrointestinal Stromal Tumor
  • Gestational Trophoblastic Neoplasms
  • Kidney cancer
  • Larynx cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma (Hodgkin & Non-Hodgkin)
  • Melanoma of the Skin
  • Mesothelioma, Malignant Pleural
  • Merkel Cell Carcinoma
  • Nasal Cavity & Paranasal Sinuses
  • Nasopharynx
  • Neuroendocrine Tumors of:
    • Appendix
    • Colon & Rectum
    • Pancreas
  • Oral Cavity cancer
  • Oropharynx (HPV-Mediated, p16+)
  • Oropharynx (p16-) & Hypopharynx
  • Ovarian cancer, Fallopian Tube & Primary Peritoneum
  • Pancreas, exocrine
  • Penile cancer
  • Plasma Cell Myeloma and Plasma Cell Disorders
    • Prostate cancer
    • Pancreas, exocrine
    • Small Intestine cancer
    • Soft Tissue Sarcoma of the Abdomen & Thoracic Visceral Organs
    • Soft Tissue Sarcoma of:
      • Head & Neck
      • Retroperitoneum
      • Trunk & Extremities
      • Unusual Histologies & Sites
    • Stomach cancer
    • Testicular cancer
    • Uterus, Carcinoma & Carcinosarcoma
    • Uterus, Sarcoma
    • Ureteral (& Renal Pelvis) cancer
    • Vaginal cancer
    • Vulvar cancer


Important Safety Information

The test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The test does NOT detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider.

The test is intended to detect cancer signals and predict where in the body the cancer signal is located. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “Cancer Signal Not Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur.

This test is available by prescription only. Additionally, the information above is only a summary and may not contain all important safety information. Click here to learn more.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Stay current on research updates, latest products and special offers

Shopping Cart